Loading...
•
Dec 31, 2025
ICU Medical Q4 2025 Earnings Report
ICU Medical reported a decrease in revenue and net loss for the fourth quarter of 2025 compared to the prior year, with adjusted diluted EPS also seeing a decline.
Key Takeaways
ICU Medical announced its fourth quarter 2025 financial results, reporting a decrease in total revenue to $540.7 million from $629.8 million in the prior year. The company experienced a net loss of $(15.7) million, or $(0.64) per diluted share, an improvement from the $(23.8) million net loss in Q4 2024. Adjusted diluted earnings per share for the quarter were $1.91, down from $2.11 in the prior year.
Total revenue for Q4 2025 was $540.7 million, a decrease from $629.8 million in Q4 2024.
GAAP net loss improved to $(15.7) million, or $(0.64) per diluted share, compared to $(23.8) million, or $(0.97) per diluted share, in Q4 2024.
Adjusted diluted earnings per share for Q4 2025 were $1.91, down from $2.11 in Q4 2024.
Adjusted EBITDA for Q4 2025 was $98.2 million, a decrease from $105.5 million in Q4 2024.
Revenue by Segment
Forward Guidance
For fiscal year 2026, ICU Medical estimates GAAP net income to be in the range of $26 million to $44 million, with GAAP net earnings per share estimated between $1.03 and $1.74. Adjusted EBITDA is projected to be in the range of $400 million to $430 million, and adjusted EPS between $7.75 and $8.45.
Positive Outlook
- Projected GAAP net income for FY 2026 is positive, ranging from $26 million to $44 million.
- Anticipated GAAP net earnings per share for FY 2026 are positive, ranging from $1.03 to $1.74.
- Adjusted EBITDA for FY 2026 is expected to be strong, ranging from $400 million to $430 million.
- Adjusted EPS for FY 2026 is projected to be robust, ranging from $7.75 to $8.45.
- The company provides clear financial targets for the upcoming fiscal year, indicating confidence in future performance.
Challenges Ahead
- The guidance for GAAP net income and EPS is a wide range, indicating potential variability in outcomes.
- No specific challenges or risks were highlighted in the guidance statement.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...